![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](bv2012contents.gif)
Acta Cryst. (2006). E62, o2817-o2818 [ doi:10.1107/S1600536806021659 ]
Abstract: The title compound, C24H18N10S2, crystallizes with two independent molecules in the asymmetric unit. The two terminal (1-phenyltetrazol-5-yl)sulfanyl groups adopt a trans configuration with respect to the central quinoxaline ring system in both independent molecules.
Online 14 June 2006
Copyright © International Union of Crystallography
IUCr Webmaster